Disc Medicine to Participate in Upcoming Investor Conferences
08 Novembro 2023 - 6:30PM
Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage
biopharmaceutical company focused on the discovery, development,
and commercialization of novel treatments for patients suffering
from serious hematologic diseases, announced today that company
management will participate in fireside chats at the Stifel 2023
Healthcare Conference on Wednesday, November 15th at 11:30 am ET.
Disc will also give presentations at the Jefferies London
Healthcare Conference on Thursday, November 16th at 9:30 am GMT /
4:30 am ET and the Piper Sandler 35th Annual Healthcare Conference
on Thursday, November 30th at 2:30 pm ET.
A live webcast of the presentations will be available through
the investor relations section of the Company's website at
ir.discmedicine.com and an archived replay will be available after
the event.
About Disc
Disc Medicine (NASDAQ:IRON) is a clinical-stage
biopharmaceutical company committed to discovering, developing, and
commercializing novel treatments for patients who suffer from
serious hematologic diseases. We are building a portfolio of
innovative, potentially first-in-class therapeutic candidates that
aim to address a wide spectrum of hematologic diseases by targeting
fundamental biological pathways of red blood cell biology,
specifically heme biosynthesis and iron homeostasis. For more
information, please visit www.discmedicine.com.
Media Contact
Peg RusconiVerge Scientific
Communicationsprusconi@vergescientific.com
Investor Relations Contact
Christina TartagliaStern Investor
Relationschristina.tartaglia@sternir.com
Disc Medicine (NASDAQ:IRON)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Disc Medicine (NASDAQ:IRON)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024